Recall Ledger

Formoterol Fumarate Inhalation Solution recall (The Ritedose Corporation)

DrugClass IIOngoing

Summary: The Ritedose Corporation is recalling Formoterol Fumarate Inhalation Solution, 20mcg/2mL, packaged in cartons of 30 individually wrapped vials (NDC 76204-030-01) and 60 individually wrapped vials (NDC 76204-030-02), Rx only, Manufactured for and by: Ritedose Pharmaceuticals, LLC, Columbia, SC. Reason: Failed Impurities/Degradation Specification.

What is being recalled

Formoterol Fumarate Inhalation Solution, 20mcg/2mL, packaged in cartons of 30 individually wrapped vials (NDC 76204-030-01) and 60 individually wrapped vials (NDC 76204-030-02), Rx only, Manufactured for and by: Ritedose Pharmaceuticals, LLC, Columbia, SC

Why

Failed Impurities/Degradation Specification

How serious is it

Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.

Where it was sold

Nationwide within the U.S

How to tell if yours is affected

Lot: 25BL0, Expires: 02/28/2027

What to do

Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.

Recall facts

Recall numberD-0073-2027
CategoryDrug
AgencyU.S. Food and Drug Administration (FDA)
SeverityClass II
StatusOngoing
Recall startedOctober 15, 2026
ReportedNovember 4, 2026
CompanyThe Ritedose Corporation
Company locationColumbia, SC, United States
Initiated byVoluntary: Firm initiated
Quantity3210 Cartons

More recalls from The Ritedose Corporation · all drug recalls · recalls from October 2026

Official FDA record